nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—SLC22A5—Dactinomycin—uterine cancer	0.0822	0.114	CbGbCtD
Lidocaine—CYP2A6—Progesterone—uterine cancer	0.0788	0.109	CbGbCtD
Lidocaine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0587	0.0815	CbGbCtD
Lidocaine—CYP3A7—Progesterone—uterine cancer	0.0539	0.0748	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0539	0.0748	CbGbCtD
Lidocaine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0409	0.0568	CbGbCtD
Lidocaine—CYP3A5—Progesterone—uterine cancer	0.0404	0.0561	CbGbCtD
Lidocaine—CYP2C8—Progesterone—uterine cancer	0.0389	0.054	CbGbCtD
Lidocaine—CYP1A2—Progesterone—uterine cancer	0.0301	0.0418	CbGbCtD
Lidocaine—CYP2C9—Progesterone—uterine cancer	0.0271	0.0376	CbGbCtD
Lidocaine—ABCB1—Progesterone—uterine cancer	0.0263	0.0365	CbGbCtD
Lidocaine—CYP2D6—Progesterone—uterine cancer	0.0248	0.0344	CbGbCtD
Lidocaine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0238	0.033	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—uterine cancer	0.0209	0.029	CbGbCtD
Lidocaine—CYP3A5—Etoposide—uterine cancer	0.0181	0.0251	CbGbCtD
Lidocaine—CYP2C8—Etoposide—uterine cancer	0.0174	0.0242	CbGbCtD
Lidocaine—CYP3A4—Progesterone—uterine cancer	0.0158	0.0219	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—uterine cancer	0.0157	0.0218	CbGbCtD
Lidocaine—CYP1A2—Etoposide—uterine cancer	0.0135	0.0187	CbGbCtD
Lidocaine—ABCB1—Etoposide—uterine cancer	0.0118	0.0164	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—uterine cancer	0.00803	0.0112	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—uterine cancer	0.00757	0.0105	CbGbCtD
Lidocaine—CYP3A4—Etoposide—uterine cancer	0.00706	0.0098	CbGbCtD
Lidocaine—CYP3A4—Doxorubicin—uterine cancer	0.00481	0.00668	CbGbCtD
Lidocaine—EGFR—uterine cervix—uterine cancer	0.00176	0.0539	CbGeAlD
Lidocaine—EGFR—mammalian vulva—uterine cancer	0.00154	0.0471	CbGeAlD
Lidocaine—CYP2C18—uterine cervix—uterine cancer	0.00152	0.0466	CbGeAlD
Lidocaine—EGFR—uterus—uterine cancer	0.00147	0.0449	CbGeAlD
Lidocaine—CYP2C18—mammalian vulva—uterine cancer	0.00133	0.0407	CbGeAlD
Lidocaine—SCN4A—renal system—uterine cancer	0.00121	0.037	CbGeAlD
Lidocaine—EGFR—female gonad—uterine cancer	0.0012	0.0367	CbGeAlD
Lidocaine—CYP2C18—vagina—uterine cancer	0.00103	0.0315	CbGeAlD
Lidocaine—SCN3A—decidua—uterine cancer	0.000958	0.0293	CbGeAlD
Lidocaine—SCN3A—renal system—uterine cancer	0.000941	0.0288	CbGeAlD
Lidocaine—SCN2A—vagina—uterine cancer	0.000775	0.0237	CbGeAlD
Lidocaine—EGFR—lymph node—uterine cancer	0.000771	0.0236	CbGeAlD
Lidocaine—SCN3A—female reproductive system—uterine cancer	0.000753	0.0231	CbGeAlD
Lidocaine—SLC22A5—myometrium—uterine cancer	0.000749	0.0229	CbGeAlD
Lidocaine—SCN3A—vagina—uterine cancer	0.000681	0.0209	CbGeAlD
Lidocaine—CYP2A6—vagina—uterine cancer	0.000681	0.0208	CbGeAlD
Lidocaine—SCN5A—vagina—uterine cancer	0.000679	0.0208	CbGeAlD
Lidocaine—SCN9A—lymph node—uterine cancer	0.000635	0.0194	CbGeAlD
Lidocaine—SLC22A5—uterine cervix—uterine cancer	0.000583	0.0178	CbGeAlD
Lidocaine—SLC22A5—renal system—uterine cancer	0.000545	0.0167	CbGeAlD
Lidocaine—CYP2C8—renal system—uterine cancer	0.000528	0.0162	CbGeAlD
Lidocaine—SLC22A5—endometrium—uterine cancer	0.000527	0.0161	CbGeAlD
Lidocaine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000525	0.00347	CcSEcCtD
Lidocaine—Stomatitis—Dactinomycin—uterine cancer	0.000522	0.00345	CcSEcCtD
Lidocaine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00344	CcSEcCtD
Lidocaine—Loss of consciousness—Progesterone—uterine cancer	0.00052	0.00344	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Etoposide—uterine cancer	0.000519	0.00343	CcSEcCtD
Lidocaine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000519	0.00343	CcSEcCtD
Lidocaine—Burning sensation—Doxorubicin—uterine cancer	0.000517	0.00342	CcSEcCtD
Lidocaine—Paralysis—Doxorubicin—uterine cancer	0.000517	0.00342	CcSEcCtD
Lidocaine—Convulsion—Progesterone—uterine cancer	0.000513	0.00339	CcSEcCtD
Lidocaine—Hypertension—Progesterone—uterine cancer	0.000511	0.00338	CcSEcCtD
Lidocaine—CYP2C8—endometrium—uterine cancer	0.00051	0.0156	CbGeAlD
Lidocaine—CYP3A5—uterine cervix—uterine cancer	0.000509	0.0156	CbGeAlD
Lidocaine—Chest pain—Progesterone—uterine cancer	0.000504	0.00333	CcSEcCtD
Lidocaine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000502	0.00332	CcSEcCtD
Lidocaine—Anxiety—Progesterone—uterine cancer	0.000502	0.00332	CcSEcCtD
Lidocaine—Blister—Doxorubicin—uterine cancer	0.000498	0.00329	CcSEcCtD
Lidocaine—Gingivitis—Epirubicin—uterine cancer	0.000495	0.00327	CcSEcCtD
Lidocaine—Hyperaesthesia—Epirubicin—uterine cancer	0.000495	0.00327	CcSEcCtD
Lidocaine—Feeling hot—Epirubicin—uterine cancer	0.000495	0.00327	CcSEcCtD
Lidocaine—CYP1A2—renal system—uterine cancer	0.000494	0.0151	CbGeAlD
Lidocaine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.00326	CcSEcCtD
Lidocaine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00049	0.00324	CcSEcCtD
Lidocaine—Confusional state—Progesterone—uterine cancer	0.000487	0.00322	CcSEcCtD
Lidocaine—SCN10A—lymph node—uterine cancer	0.000484	0.0148	CbGeAlD
Lidocaine—Anaphylactic shock—Progesterone—uterine cancer	0.000483	0.00319	CcSEcCtD
Lidocaine—Oedema—Progesterone—uterine cancer	0.000483	0.00319	CcSEcCtD
Lidocaine—Cardiac arrest—Etoposide—uterine cancer	0.000478	0.00316	CcSEcCtD
Lidocaine—CYP3A5—renal system—uterine cancer	0.000476	0.0146	CbGeAlD
Lidocaine—Shock—Progesterone—uterine cancer	0.000475	0.00314	CcSEcCtD
Lidocaine—Nervous system disorder—Progesterone—uterine cancer	0.000474	0.00313	CcSEcCtD
Lidocaine—CYP2B6—renal system—uterine cancer	0.000473	0.0145	CbGeAlD
Lidocaine—Petechiae—Epirubicin—uterine cancer	0.000472	0.00312	CcSEcCtD
Lidocaine—Dysphonia—Epirubicin—uterine cancer	0.000472	0.00312	CcSEcCtD
Lidocaine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000471	0.00312	CcSEcCtD
Lidocaine—Hyperhidrosis—Progesterone—uterine cancer	0.000467	0.00309	CcSEcCtD
Lidocaine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000465	0.00307	CcSEcCtD
Lidocaine—Hyperaesthesia—Doxorubicin—uterine cancer	0.000458	0.00303	CcSEcCtD
Lidocaine—Feeling hot—Doxorubicin—uterine cancer	0.000458	0.00303	CcSEcCtD
Lidocaine—Gingivitis—Doxorubicin—uterine cancer	0.000458	0.00303	CcSEcCtD
Lidocaine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00302	CcSEcCtD
Lidocaine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000455	0.00301	CcSEcCtD
Lidocaine—Hypotension—Progesterone—uterine cancer	0.000451	0.00298	CcSEcCtD
Lidocaine—Flushing—Dactinomycin—uterine cancer	0.000446	0.00295	CcSEcCtD
Lidocaine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000441	0.00292	CcSEcCtD
Lidocaine—SCN3A—lymph node—uterine cancer	0.000441	0.0135	CbGeAlD
Lidocaine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000438	0.00289	CcSEcCtD
Lidocaine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000438	0.00289	CcSEcCtD
Lidocaine—Dysphonia—Doxorubicin—uterine cancer	0.000437	0.00289	CcSEcCtD
Lidocaine—Petechiae—Doxorubicin—uterine cancer	0.000437	0.00289	CcSEcCtD
Lidocaine—SLC22A5—female reproductive system—uterine cancer	0.000437	0.0134	CbGeAlD
Lidocaine—Dysphagia—Etoposide—uterine cancer	0.000434	0.00287	CcSEcCtD
Lidocaine—Paraesthesia—Progesterone—uterine cancer	0.000434	0.00287	CcSEcCtD
Lidocaine—Chills—Dactinomycin—uterine cancer	0.000431	0.00285	CcSEcCtD
Lidocaine—Dyspnoea—Progesterone—uterine cancer	0.000431	0.00285	CcSEcCtD
Lidocaine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.00285	CcSEcCtD
Lidocaine—Somnolence—Progesterone—uterine cancer	0.000429	0.00284	CcSEcCtD
Lidocaine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.00284	CcSEcCtD
Lidocaine—Bronchospasm—Etoposide—uterine cancer	0.000427	0.00283	CcSEcCtD
Lidocaine—Sweating increased—Etoposide—uterine cancer	0.000423	0.0028	CcSEcCtD
Lidocaine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.0028	CcSEcCtD
Lidocaine—CYP2C8—female reproductive system—uterine cancer	0.000423	0.0129	CbGeAlD
Lidocaine—Erythema—Dactinomycin—uterine cancer	0.000418	0.00277	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Progesterone—uterine cancer	0.000417	0.00276	CcSEcCtD
Lidocaine—Pain—Progesterone—uterine cancer	0.000413	0.00273	CcSEcCtD
Lidocaine—Dysarthria—Epirubicin—uterine cancer	0.00041	0.00271	CcSEcCtD
Lidocaine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.0027	CcSEcCtD
Lidocaine—Atrioventricular block—Epirubicin—uterine cancer	0.0004	0.00265	CcSEcCtD
Lidocaine—Feeling abnormal—Progesterone—uterine cancer	0.000398	0.00263	CcSEcCtD
Lidocaine—SLC22A5—female gonad—uterine cancer	0.000397	0.0122	CbGeAlD
Lidocaine—SLC22A5—vagina—uterine cancer	0.000395	0.0121	CbGeAlD
Lidocaine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.0026	CcSEcCtD
Lidocaine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00258	CcSEcCtD
Lidocaine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000389	0.00257	CcSEcCtD
Lidocaine—Ventricular tachycardia—Epirubicin—uterine cancer	0.000388	0.00257	CcSEcCtD
Lidocaine—Urticaria—Progesterone—uterine cancer	0.000384	0.00254	CcSEcCtD
Lidocaine—Dermatitis contact—Epirubicin—uterine cancer	0.000384	0.00254	CcSEcCtD
Lidocaine—CYP2C8—vagina—uterine cancer	0.000382	0.0117	CbGeAlD
Lidocaine—Dysarthria—Doxorubicin—uterine cancer	0.00038	0.00251	CcSEcCtD
Lidocaine—Neuropathy peripheral—Etoposide—uterine cancer	0.00038	0.00251	CcSEcCtD
Lidocaine—CYP2B6—female reproductive system—uterine cancer	0.000379	0.0116	CbGeAlD
Lidocaine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.0025	CcSEcCtD
Lidocaine—Stomatitis—Etoposide—uterine cancer	0.000378	0.0025	CcSEcCtD
Lidocaine—CYP2C9—female reproductive system—uterine cancer	0.000375	0.0115	CbGeAlD
Lidocaine—Skin exfoliation—Epirubicin—uterine cancer	0.000371	0.00245	CcSEcCtD
Lidocaine—Atrioventricular block—Doxorubicin—uterine cancer	0.00037	0.00245	CcSEcCtD
Lidocaine—Neuropathy—Epirubicin—uterine cancer	0.000364	0.00241	CcSEcCtD
Lidocaine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000361	0.00238	CcSEcCtD
Lidocaine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000359	0.00238	CcSEcCtD
Lidocaine—CYP3A4—renal system—uterine cancer	0.000357	0.0109	CbGeAlD
Lidocaine—Hypersensitivity—Progesterone—uterine cancer	0.000356	0.00235	CcSEcCtD
Lidocaine—Dermatitis contact—Doxorubicin—uterine cancer	0.000355	0.00235	CcSEcCtD
Lidocaine—Coma—Epirubicin—uterine cancer	0.000355	0.00235	CcSEcCtD
Lidocaine—CYP2D6—renal system—uterine cancer	0.000352	0.0108	CbGeAlD
Lidocaine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000348	0.0023	CcSEcCtD
Lidocaine—ABCB1—myometrium—uterine cancer	0.000348	0.0106	CbGeAlD
Lidocaine—CYP3A5—female gonad—uterine cancer	0.000347	0.0106	CbGeAlD
Lidocaine—Asthenia—Progesterone—uterine cancer	0.000347	0.00229	CcSEcCtD
Lidocaine—Hypoaesthesia—Etoposide—uterine cancer	0.000346	0.00229	CcSEcCtD
Lidocaine—CYP3A5—vagina—uterine cancer	0.000345	0.0106	CbGeAlD
Lidocaine—Skin exfoliation—Doxorubicin—uterine cancer	0.000343	0.00227	CcSEcCtD
Lidocaine—CYP2B6—vagina—uterine cancer	0.000343	0.0105	CbGeAlD
Lidocaine—Oedema—Dactinomycin—uterine cancer	0.000341	0.00226	CcSEcCtD
Lidocaine—Neuropathy—Doxorubicin—uterine cancer	0.000337	0.00223	CcSEcCtD
Lidocaine—Coma—Doxorubicin—uterine cancer	0.000328	0.00217	CcSEcCtD
Lidocaine—Eye disorder—Etoposide—uterine cancer	0.000325	0.00215	CcSEcCtD
Lidocaine—Flushing—Etoposide—uterine cancer	0.000323	0.00213	CcSEcCtD
Lidocaine—Cardiac disorder—Etoposide—uterine cancer	0.000323	0.00213	CcSEcCtD
Lidocaine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000322	0.00213	CcSEcCtD
Lidocaine—Dizziness—Progesterone—uterine cancer	0.000319	0.00211	CcSEcCtD
Lidocaine—Angiopathy—Etoposide—uterine cancer	0.000316	0.00209	CcSEcCtD
Lidocaine—Immune system disorder—Etoposide—uterine cancer	0.000314	0.00208	CcSEcCtD
Lidocaine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000314	0.00208	CcSEcCtD
Lidocaine—Chills—Etoposide—uterine cancer	0.000312	0.00206	CcSEcCtD
Lidocaine—Vomiting—Progesterone—uterine cancer	0.000307	0.00203	CcSEcCtD
Lidocaine—Rash—Progesterone—uterine cancer	0.000305	0.00201	CcSEcCtD
Lidocaine—Dermatitis—Progesterone—uterine cancer	0.000304	0.00201	CcSEcCtD
Lidocaine—Headache—Progesterone—uterine cancer	0.000303	0.002	CcSEcCtD
Lidocaine—Dysgeusia—Etoposide—uterine cancer	0.000296	0.00196	CcSEcCtD
Lidocaine—Dermatitis bullous—Epirubicin—uterine cancer	0.000295	0.00195	CcSEcCtD
Lidocaine—Back pain—Etoposide—uterine cancer	0.000293	0.00194	CcSEcCtD
Lidocaine—Pain—Dactinomycin—uterine cancer	0.000292	0.00193	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000291	0.00193	CcSEcCtD
Lidocaine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000289	0.00191	CcSEcCtD
Lidocaine—Nausea—Progesterone—uterine cancer	0.000287	0.0019	CcSEcCtD
Lidocaine—CYP3A4—female reproductive system—uterine cancer	0.000286	0.00877	CbGeAlD
Lidocaine—Osteoarthritis—Epirubicin—uterine cancer	0.000282	0.00186	CcSEcCtD
Lidocaine—Diplopia—Epirubicin—uterine cancer	0.000282	0.00186	CcSEcCtD
Lidocaine—CYP2D6—female reproductive system—uterine cancer	0.000282	0.00863	CbGeAlD
Lidocaine—Feeling abnormal—Dactinomycin—uterine cancer	0.000281	0.00186	CcSEcCtD
Lidocaine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000278	0.00184	CcSEcCtD
Lidocaine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00182	CcSEcCtD
Lidocaine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00182	CcSEcCtD
Lidocaine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00181	CcSEcCtD
Lidocaine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000273	0.0018	CcSEcCtD
Lidocaine—ABCB1—epithelium—uterine cancer	0.000273	0.00835	CbGeAlD
Lidocaine—ABCB1—uterine cervix—uterine cancer	0.00027	0.00828	CbGeAlD
Lidocaine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000269	0.00178	CcSEcCtD
Lidocaine—Cardiac arrest—Epirubicin—uterine cancer	0.000268	0.00177	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—uterine cancer	0.000266	0.00176	CcSEcCtD
Lidocaine—Convulsion—Etoposide—uterine cancer	0.000262	0.00173	CcSEcCtD
Lidocaine—Hypertension—Etoposide—uterine cancer	0.000261	0.00173	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—uterine cancer	0.000261	0.00172	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—uterine cancer	0.000261	0.00172	CcSEcCtD
Lidocaine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00026	0.00172	CcSEcCtD
Lidocaine—Chest pain—Etoposide—uterine cancer	0.000258	0.0017	CcSEcCtD
Lidocaine—ABCB1—decidua—uterine cancer	0.000258	0.00789	CbGeAlD
Lidocaine—CYP2D6—female gonad—uterine cancer	0.000256	0.00785	CbGeAlD
Lidocaine—SLC22A5—lymph node—uterine cancer	0.000255	0.00782	CbGeAlD
Lidocaine—ABCB1—renal system—uterine cancer	0.000253	0.00775	CbGeAlD
Lidocaine—Hypersensitivity—Dactinomycin—uterine cancer	0.000252	0.00166	CcSEcCtD
Lidocaine—Confusional state—Etoposide—uterine cancer	0.000249	0.00165	CcSEcCtD
Lidocaine—Cardiac arrest—Doxorubicin—uterine cancer	0.000248	0.00164	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—uterine cancer	0.000247	0.00163	CcSEcCtD
Lidocaine—Asthenia—Dactinomycin—uterine cancer	0.000245	0.00162	CcSEcCtD
Lidocaine—ABCB1—endometrium—uterine cancer	0.000245	0.00749	CbGeAlD
Lidocaine—Asthma—Epirubicin—uterine cancer	0.000244	0.00161	CcSEcCtD
Lidocaine—Dysphagia—Epirubicin—uterine cancer	0.000244	0.00161	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—uterine cancer	0.000239	0.00158	CcSEcCtD
Lidocaine—ABCB1—mammalian vulva—uterine cancer	0.000237	0.00725	CbGeAlD
Lidocaine—Hypotension—Etoposide—uterine cancer	0.000231	0.00153	CcSEcCtD
Lidocaine—ABCB1—uterus—uterine cancer	0.000225	0.0069	CbGeAlD
Lidocaine—Asthma—Doxorubicin—uterine cancer	0.000225	0.00149	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—uterine cancer	0.000225	0.00149	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—uterine cancer	0.000222	0.00147	CcSEcCtD
Lidocaine—Dyspnoea—Etoposide—uterine cancer	0.00022	0.00146	CcSEcCtD
Lidocaine—Somnolence—Etoposide—uterine cancer	0.00022	0.00145	CcSEcCtD
Lidocaine—Drowsiness—Epirubicin—uterine cancer	0.000217	0.00144	CcSEcCtD
Lidocaine—Vomiting—Dactinomycin—uterine cancer	0.000217	0.00144	CcSEcCtD
Lidocaine—Rash—Dactinomycin—uterine cancer	0.000215	0.00142	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000213	0.00141	CcSEcCtD
Lidocaine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000213	0.00141	CcSEcCtD
Lidocaine—Stomatitis—Epirubicin—uterine cancer	0.000212	0.0014	CcSEcCtD
Lidocaine—Pain—Etoposide—uterine cancer	0.000211	0.0014	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—uterine cancer	0.000204	0.00135	CcSEcCtD
Lidocaine—Nausea—Dactinomycin—uterine cancer	0.000203	0.00134	CcSEcCtD
Lidocaine—ABCB1—female reproductive system—uterine cancer	0.000203	0.0062	CbGeAlD
Lidocaine—Drowsiness—Doxorubicin—uterine cancer	0.000201	0.00133	CcSEcCtD
Lidocaine—Bradycardia—Epirubicin—uterine cancer	0.000198	0.00131	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000197	0.0013	CcSEcCtD
Lidocaine—Urticaria—Etoposide—uterine cancer	0.000196	0.0013	CcSEcCtD
Lidocaine—Haemoglobin—Epirubicin—uterine cancer	0.000196	0.0013	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—uterine cancer	0.000196	0.00129	CcSEcCtD
Lidocaine—Rhinitis—Epirubicin—uterine cancer	0.000195	0.00129	CcSEcCtD
Lidocaine—Haemorrhage—Epirubicin—uterine cancer	0.000195	0.00129	CcSEcCtD
Lidocaine—Hypoaesthesia—Epirubicin—uterine cancer	0.000194	0.00128	CcSEcCtD
Lidocaine—Visual impairment—Epirubicin—uterine cancer	0.000188	0.00124	CcSEcCtD
Lidocaine—ABCB1—female gonad—uterine cancer	0.000184	0.00565	CbGeAlD
Lidocaine—Bradycardia—Doxorubicin—uterine cancer	0.000184	0.00121	CcSEcCtD
Lidocaine—ABCB1—vagina—uterine cancer	0.000183	0.00561	CbGeAlD
Lidocaine—Eye disorder—Epirubicin—uterine cancer	0.000182	0.0012	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—uterine cancer	0.000182	0.0012	CcSEcCtD
Lidocaine—Tinnitus—Epirubicin—uterine cancer	0.000182	0.0012	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—uterine cancer	0.000181	0.0012	CcSEcCtD
Lidocaine—Flushing—Epirubicin—uterine cancer	0.000181	0.0012	CcSEcCtD
Lidocaine—Cardiac disorder—Epirubicin—uterine cancer	0.000181	0.0012	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—uterine cancer	0.000181	0.0012	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—uterine cancer	0.00018	0.00119	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000179	0.00119	CcSEcCtD
Lidocaine—Asthenia—Etoposide—uterine cancer	0.000177	0.00117	CcSEcCtD
Lidocaine—Angiopathy—Epirubicin—uterine cancer	0.000177	0.00117	CcSEcCtD
Lidocaine—Immune system disorder—Epirubicin—uterine cancer	0.000176	0.00116	CcSEcCtD
Lidocaine—Chills—Epirubicin—uterine cancer	0.000175	0.00116	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—uterine cancer	0.000174	0.00115	CcSEcCtD
Lidocaine—Erythema—Epirubicin—uterine cancer	0.00017	0.00112	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—uterine cancer	0.000169	0.00111	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—uterine cancer	0.000168	0.00111	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—uterine cancer	0.000167	0.00111	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—uterine cancer	0.000167	0.00111	CcSEcCtD
Lidocaine—Tension—Epirubicin—uterine cancer	0.000167	0.0011	CcSEcCtD
Lidocaine—Dysgeusia—Epirubicin—uterine cancer	0.000166	0.0011	CcSEcCtD
Lidocaine—Nervousness—Epirubicin—uterine cancer	0.000165	0.00109	CcSEcCtD
Lidocaine—Back pain—Epirubicin—uterine cancer	0.000164	0.00109	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—uterine cancer	0.000164	0.00108	CcSEcCtD
Lidocaine—Dizziness—Etoposide—uterine cancer	0.000163	0.00108	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—uterine cancer	0.000163	0.00108	CcSEcCtD
Lidocaine—Chills—Doxorubicin—uterine cancer	0.000162	0.00107	CcSEcCtD
Lidocaine—Vision blurred—Epirubicin—uterine cancer	0.00016	0.00106	CcSEcCtD
Lidocaine—Vomiting—Etoposide—uterine cancer	0.000157	0.00104	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—uterine cancer	0.000157	0.00104	CcSEcCtD
Lidocaine—Agitation—Epirubicin—uterine cancer	0.000156	0.00103	CcSEcCtD
Lidocaine—Rash—Etoposide—uterine cancer	0.000156	0.00103	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—uterine cancer	0.000156	0.00103	CcSEcCtD
Lidocaine—Headache—Etoposide—uterine cancer	0.000155	0.00102	CcSEcCtD
Lidocaine—Tension—Doxorubicin—uterine cancer	0.000154	0.00102	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—uterine cancer	0.000154	0.00102	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—uterine cancer	0.000153	0.00101	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—uterine cancer	0.000152	0.001	CcSEcCtD
Lidocaine—Loss of consciousness—Epirubicin—uterine cancer	0.000149	0.000986	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—uterine cancer	0.000148	0.000978	CcSEcCtD
Lidocaine—Convulsion—Epirubicin—uterine cancer	0.000147	0.000972	CcSEcCtD
Lidocaine—Nausea—Etoposide—uterine cancer	0.000147	0.00097	CcSEcCtD
Lidocaine—Hypertension—Epirubicin—uterine cancer	0.000147	0.000969	CcSEcCtD
Lidocaine—Chest pain—Epirubicin—uterine cancer	0.000144	0.000955	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—uterine cancer	0.000144	0.000954	CcSEcCtD
Lidocaine—Anxiety—Epirubicin—uterine cancer	0.000144	0.000952	CcSEcCtD
Lidocaine—Confusional state—Epirubicin—uterine cancer	0.00014	0.000923	CcSEcCtD
Lidocaine—Oedema—Epirubicin—uterine cancer	0.000138	0.000916	CcSEcCtD
Lidocaine—Anaphylactic shock—Epirubicin—uterine cancer	0.000138	0.000916	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—uterine cancer	0.000138	0.000913	CcSEcCtD
Lidocaine—Shock—Epirubicin—uterine cancer	0.000136	0.000901	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—uterine cancer	0.000136	0.0009	CcSEcCtD
Lidocaine—Nervous system disorder—Epirubicin—uterine cancer	0.000136	0.000898	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—uterine cancer	0.000136	0.000896	CcSEcCtD
Lidocaine—Hyperhidrosis—Epirubicin—uterine cancer	0.000134	0.000885	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—uterine cancer	0.000134	0.000884	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—uterine cancer	0.000133	0.000881	CcSEcCtD
Lidocaine—Hypotension—Epirubicin—uterine cancer	0.000129	0.000856	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—uterine cancer	0.000129	0.000854	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000128	0.000847	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—uterine cancer	0.000128	0.000847	CcSEcCtD
Lidocaine—Shock—Doxorubicin—uterine cancer	0.000126	0.000834	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—uterine cancer	0.000126	0.000831	CcSEcCtD
Lidocaine—Paraesthesia—Epirubicin—uterine cancer	0.000124	0.000822	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000124	0.000819	CcSEcCtD
Lidocaine—Dyspnoea—Epirubicin—uterine cancer	0.000123	0.000816	CcSEcCtD
Lidocaine—Somnolence—Epirubicin—uterine cancer	0.000123	0.000814	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—uterine cancer	0.00012	0.000792	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00012	0.000791	CcSEcCtD
Lidocaine—ABCB1—lymph node—uterine cancer	0.000119	0.00363	CbGeAlD
Lidocaine—Pain—Epirubicin—uterine cancer	0.000118	0.000783	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—uterine cancer	0.000115	0.000761	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—uterine cancer	0.000114	0.000755	CcSEcCtD
Lidocaine—Feeling abnormal—Epirubicin—uterine cancer	0.000114	0.000755	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—uterine cancer	0.000114	0.000753	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000111	0.000732	CcSEcCtD
Lidocaine—Urticaria—Epirubicin—uterine cancer	0.00011	0.000727	CcSEcCtD
Lidocaine—Pain—Doxorubicin—uterine cancer	0.00011	0.000725	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—uterine cancer	0.000106	0.000698	CcSEcCtD
Lidocaine—Hypersensitivity—Epirubicin—uterine cancer	0.000102	0.000675	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—uterine cancer	0.000102	0.000673	CcSEcCtD
Lidocaine—Asthenia—Epirubicin—uterine cancer	9.94e-05	0.000657	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—uterine cancer	9.44e-05	0.000624	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—uterine cancer	9.19e-05	0.000608	CcSEcCtD
Lidocaine—Dizziness—Epirubicin—uterine cancer	9.16e-05	0.000606	CcSEcCtD
Lidocaine—Vomiting—Epirubicin—uterine cancer	8.81e-05	0.000582	CcSEcCtD
Lidocaine—Rash—Epirubicin—uterine cancer	8.73e-05	0.000577	CcSEcCtD
Lidocaine—Dermatitis—Epirubicin—uterine cancer	8.72e-05	0.000577	CcSEcCtD
Lidocaine—Headache—Epirubicin—uterine cancer	8.68e-05	0.000574	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—uterine cancer	8.47e-05	0.00056	CcSEcCtD
Lidocaine—Nausea—Epirubicin—uterine cancer	8.23e-05	0.000544	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—uterine cancer	8.15e-05	0.000539	CcSEcCtD
Lidocaine—Rash—Doxorubicin—uterine cancer	8.08e-05	0.000534	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—uterine cancer	8.07e-05	0.000534	CcSEcCtD
Lidocaine—Headache—Doxorubicin—uterine cancer	8.03e-05	0.000531	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—uterine cancer	7.61e-05	0.000503	CcSEcCtD
Lidocaine—CYP2B6—Metabolism—POLD1—uterine cancer	2.45e-05	0.000255	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	2.44e-05	0.000255	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SOCS3—uterine cancer	2.43e-05	0.000253	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POLD1—uterine cancer	2.39e-05	0.000249	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKR1C3—uterine cancer	2.38e-05	0.000248	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.33e-05	0.000243	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.33e-05	0.000243	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.31e-05	0.000241	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—PIK3CA—uterine cancer	2.3e-05	0.00024	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKR1B1—uterine cancer	2.3e-05	0.00024	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—STAR—uterine cancer	2.3e-05	0.00024	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.29e-05	0.000238	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.27e-05	0.000237	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—KRAS—uterine cancer	2.27e-05	0.000236	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.24e-05	0.000233	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.18e-05	0.000227	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB2—uterine cancer	2.18e-05	0.000227	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.17e-05	0.000226	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—STAR—uterine cancer	2.17e-05	0.000226	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.17e-05	0.000226	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—uterine cancer	2.16e-05	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKR1C3—uterine cancer	2.15e-05	0.000224	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—STAR—uterine cancer	2.15e-05	0.000224	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.15e-05	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN2B—uterine cancer	2.15e-05	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—uterine cancer	2.13e-05	0.000222	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.12e-05	0.000221	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—uterine cancer	2.1e-05	0.000219	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—MTHFR—uterine cancer	2.1e-05	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PGR—uterine cancer	2.1e-05	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB2—uterine cancer	2.1e-05	0.000218	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POLD1—uterine cancer	2.07e-05	0.000216	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.05e-05	0.000214	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—RRM2—uterine cancer	2.04e-05	0.000212	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGFR2—uterine cancer	2.02e-05	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1B—uterine cancer	2.02e-05	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—EP300—uterine cancer	2.01e-05	0.000209	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—YWHAE—uterine cancer	2e-05	0.000208	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—RRM2—uterine cancer	1.99e-05	0.000208	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—DCN—uterine cancer	1.98e-05	0.000206	CbGpPWpGaD
Lidocaine—EGFR—Disease—SMAD3—uterine cancer	1.96e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.96e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.96e-05	0.000204	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1B—uterine cancer	1.94e-05	0.000202	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.94e-05	0.000202	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—DCN—uterine cancer	1.93e-05	0.000202	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—uterine cancer	1.93e-05	0.000201	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FBXW7—uterine cancer	1.92e-05	0.0002	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—uterine cancer	1.91e-05	0.000199	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—uterine cancer	1.9e-05	0.000198	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKT1—uterine cancer	1.88e-05	0.000196	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—uterine cancer	1.88e-05	0.000196	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGFR2—uterine cancer	1.87e-05	0.000195	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.86e-05	0.000194	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PTEN—uterine cancer	1.86e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.85e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—STK11—uterine cancer	1.85e-05	0.000193	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—AKT1—uterine cancer	1.85e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—STAR—uterine cancer	1.83e-05	0.000191	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.83e-05	0.000191	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.82e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.81e-05	0.000189	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POLD1—uterine cancer	1.8e-05	0.000188	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTHFR—uterine cancer	1.8e-05	0.000187	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PTEN—uterine cancer	1.79e-05	0.000186	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—EP300—uterine cancer	1.77e-05	0.000185	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.76e-05	0.000184	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.75e-05	0.000182	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—RRM2—uterine cancer	1.73e-05	0.00018	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.72e-05	0.000179	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—STK11—uterine cancer	1.7e-05	0.000177	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.7e-05	0.000177	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POLD1—uterine cancer	1.7e-05	0.000177	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000176	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POLD1—uterine cancer	1.68e-05	0.000176	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STK11—uterine cancer	1.68e-05	0.000175	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—DCN—uterine cancer	1.68e-05	0.000175	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CCL2—uterine cancer	1.67e-05	0.000174	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—uterine cancer	1.66e-05	0.000173	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—uterine cancer	1.62e-05	0.000169	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.6e-05	0.000167	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—uterine cancer	1.59e-05	0.000166	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.59e-05	0.000166	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.58e-05	0.000165	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.58e-05	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SOCS3—uterine cancer	1.57e-05	0.000164	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.55e-05	0.000162	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—uterine cancer	1.51e-05	0.000157	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—RRM2—uterine cancer	1.5e-05	0.000157	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN2B—uterine cancer	1.5e-05	0.000157	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.49e-05	0.000155	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—DCN—uterine cancer	1.46e-05	0.000152	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1R—uterine cancer	1.46e-05	0.000152	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POLD1—uterine cancer	1.44e-05	0.00015	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—uterine cancer	1.43e-05	0.000149	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RRM2—uterine cancer	1.42e-05	0.000148	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.000148	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—STAR—uterine cancer	1.42e-05	0.000148	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RRM2—uterine cancer	1.4e-05	0.000146	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—MTHFR—uterine cancer	1.39e-05	0.000145	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—DCN—uterine cancer	1.38e-05	0.000143	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000143	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—uterine cancer	1.38e-05	0.000143	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—uterine cancer	1.37e-05	0.000143	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SMAD3—uterine cancer	1.37e-05	0.000143	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—STK11—uterine cancer	1.37e-05	0.000143	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.37e-05	0.000143	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—DCN—uterine cancer	1.36e-05	0.000142	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.35e-05	0.00014	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.34e-05	0.00014	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—STK11—uterine cancer	1.34e-05	0.00014	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CXCL8—uterine cancer	1.32e-05	0.000137	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PIK3CA—uterine cancer	1.31e-05	0.000137	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.31e-05	0.000137	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGFR2—uterine cancer	1.31e-05	0.000136	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000135	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000135	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000134	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—MTHFR—uterine cancer	1.28e-05	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—uterine cancer	1.27e-05	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PIK3CA—uterine cancer	1.26e-05	0.000131	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.22e-05	0.000128	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—uterine cancer	1.21e-05	0.000127	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—uterine cancer	1.21e-05	0.000127	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000126	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RRM2—uterine cancer	1.2e-05	0.000125	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1B—uterine cancer	1.18e-05	0.000123	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—uterine cancer	1.17e-05	0.000122	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTEN—uterine cancer	1.17e-05	0.000122	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—uterine cancer	1.17e-05	0.000122	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—DCN—uterine cancer	1.17e-05	0.000121	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—STK11—uterine cancer	1.16e-05	0.000121	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ESR1—uterine cancer	1.12e-05	0.000117	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—EP300—uterine cancer	1.11e-05	0.000116	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—uterine cancer	1.11e-05	0.000116	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POLD1—uterine cancer	1.11e-05	0.000116	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.000114	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000114	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1B—uterine cancer	1.09e-05	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTEN—uterine cancer	1.08e-05	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—uterine cancer	1.07e-05	0.000112	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—uterine cancer	1.06e-05	0.00011	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.000108	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.000108	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000108	CbGpPWpGaD
Lidocaine—EGFR—Immune System—EP300—uterine cancer	1.03e-05	0.000108	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000107	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—uterine cancer	1.03e-05	0.000107	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—uterine cancer	1.03e-05	0.000107	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000105	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—STK11—uterine cancer	1.01e-05	0.000105	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—uterine cancer	1.01e-05	0.000105	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTEN—uterine cancer	1e-05	0.000104	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—uterine cancer	9.86e-06	0.000103	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—uterine cancer	9.67e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—uterine cancer	9.54e-06	9.95e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.53e-06	9.94e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—STK11—uterine cancer	9.53e-06	9.94e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP19A1—uterine cancer	9.45e-06	9.85e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—STK11—uterine cancer	9.45e-06	9.85e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RRM2—uterine cancer	9.26e-06	9.66e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—uterine cancer	9.11e-06	9.49e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—DCN—uterine cancer	8.99e-06	9.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—uterine cancer	8.93e-06	9.31e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.87e-06	9.25e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—uterine cancer	8.73e-06	9.1e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.47e-06	8.83e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.46e-06	8.82e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—uterine cancer	8.37e-06	8.72e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—uterine cancer	8.32e-06	8.67e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—uterine cancer	8.23e-06	8.58e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—uterine cancer	8.22e-06	8.57e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP19A1—uterine cancer	8.08e-06	8.42e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—STK11—uterine cancer	8.08e-06	8.42e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKR1C3—uterine cancer	8e-06	8.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—uterine cancer	7.79e-06	8.12e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—uterine cancer	7.75e-06	8.08e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—uterine cancer	7.74e-06	8.07e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.69e-06	8.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—uterine cancer	7.68e-06	8.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—uterine cancer	7.65e-06	7.97e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—uterine cancer	7.61e-06	7.93e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—uterine cancer	7.6e-06	7.93e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.58e-06	7.9e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—uterine cancer	7.39e-06	7.71e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.23e-06	7.54e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—uterine cancer	7.19e-06	7.49e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—uterine cancer	7.16e-06	7.47e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—uterine cancer	7.11e-06	7.41e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—uterine cancer	7.1e-06	7.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—uterine cancer	7.07e-06	7.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—uterine cancer	7.06e-06	7.36e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—uterine cancer	7.01e-06	7.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—uterine cancer	6.84e-06	7.13e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—uterine cancer	6.78e-06	7.07e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—uterine cancer	6.72e-06	7.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—uterine cancer	6.68e-06	6.97e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—uterine cancer	6.53e-06	6.81e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—uterine cancer	6.33e-06	6.6e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.26e-06	6.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—uterine cancer	6.25e-06	6.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—uterine cancer	6.25e-06	6.51e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—STK11—uterine cancer	6.23e-06	6.5e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.23e-06	6.5e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—uterine cancer	6.07e-06	6.33e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—uterine cancer	5.77e-06	6.01e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—uterine cancer	5.73e-06	5.98e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—uterine cancer	5.61e-06	5.84e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—uterine cancer	5.47e-06	5.7e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—uterine cancer	5.47e-06	5.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—uterine cancer	5.38e-06	5.61e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.35e-06	5.58e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—uterine cancer	5.35e-06	5.57e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—uterine cancer	5.01e-06	5.23e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—uterine cancer	4.94e-06	5.15e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—uterine cancer	4.85e-06	5.06e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—uterine cancer	4.78e-06	4.98e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—uterine cancer	4.68e-06	4.88e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—uterine cancer	4.63e-06	4.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—uterine cancer	4.57e-06	4.77e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—uterine cancer	4.47e-06	4.66e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—uterine cancer	4.23e-06	4.41e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—uterine cancer	4.1e-06	4.27e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—uterine cancer	4.05e-06	4.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—uterine cancer	4.04e-06	4.21e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—uterine cancer	4.03e-06	4.2e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—uterine cancer	3.99e-06	4.15e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.95e-06	4.12e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—uterine cancer	3.95e-06	4.12e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—uterine cancer	3.8e-06	3.96e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—uterine cancer	3.77e-06	3.93e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.42e-06	3.57e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—uterine cancer	3.38e-06	3.52e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—uterine cancer	3.3e-06	3.44e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—uterine cancer	3.23e-06	3.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—uterine cancer	3.22e-06	3.36e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.98e-06	3.11e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.81e-06	2.93e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—uterine cancer	2.8e-06	2.92e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.79e-06	2.91e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—uterine cancer	2.61e-06	2.72e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—uterine cancer	2.49e-06	2.59e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—uterine cancer	2.44e-06	2.54e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.38e-06	2.48e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—uterine cancer	2.3e-06	2.39e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—uterine cancer	2.28e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—uterine cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.84e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—uterine cancer	1.5e-06	1.57e-05	CbGpPWpGaD
